MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 336 participants.
Also called NCT01307046
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 336 participants
- Sponsor
- Registry
-
NCT01307046
-
- Other papers using this trial's data
- Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01307046. Randomized; double masking; primary purpose treatment. Start 2011-03-29 (actual); primary completion 2012-02-07 (actual). Results posted on 2013-03-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)
- Condition
- Hypertension
- Intervention (Drug)
- MK-0954A
- Intervention (Drug)
- Losartan
- Intervention (Drug)
- Placebo to MK-0954A
- Intervention (Drug)
- Placebo to losartan 100 mg
- Intervention (Drug)
- Placebo to losartan 50 mg
- Lead sponsor
- Organon and Co
Record details
- Record id
cardio:ct-nct01307046- Content hash
624a0c4694e996102006a84ed22852551abe83c4fe02258d429e036065e258f4